Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
Call for Outstanding Global Postdoctoral Fellows in the Biomaterials and Regenerative Medicine Group
research team based at the School of Biomedical Sciences and Engineering, South China University of Technology (SCUT). Our research focuses on designing functional biomaterials that replicate the biochemical
-
that Quadram Early Career fellows will either gain external longer-term fellowships or win suitable faculty positions. We have prepared a few Q&As relating to this role which you can access on our
-
proposal (maximum 10 pages), addressing how the proposal aligns with one or more key research areas, as well as the objectives and purpose of the proposed project, the state of the art, originality and
-
regulation and other aspects of cellular signal transduction. We use our structural and mechanistic insights to drive development of novel anti-cancer drugs. Systems of current interest in the lab include RAF
-
to promote public health particularly among high-risk and underserved populations. We conduct groundbreaking research that advances treatment, we educate tomorrow's physician/researchers, and we work with
-
care to patients of all ages; we conduct research that advances treatment; we educate tomorrow's physician/researchers; we reach out to underserved members of our community; and we work with amazing
-
of America’s Best Large Employers and America’s Best Employers for Women, Computerworld magazine’s list of 100 Best Places to Work in Information Technology, DiversityInc Top Hospitals & Health Systems and
-
and underserved populations. We conduct groundbreaking research that advances treatment, we educate tomorrow's physician/researchers, and we work with amazing partners, including other Harvard Medical
-
& mathematical sciences, security, arts, business and law. This distinctive Academic Fellowship scheme is part of a major strategic investment by King’s in “AI+”, which aims to accelerate innovation in responsible
-
/graduate applying for their first postdoctoral fellowship in epigenetics in leukemia. Led by Dr. Emily Heikamp, MD PhD, our work focuses on high-risk forms of pediatric leukemia that are driven by oncogenic